Botanix Pharmaceuticals Statistics
Total Valuation
BXPHF has a market cap or net worth of 382.98 million. The enterprise value is 352.01 million.
| Market Cap | 382.98M |
| Enterprise Value | 352.01M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.96B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +24.08% |
| Shares Change (QoQ) | +16.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.72B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 299.09 |
| PB Ratio | 6.69 |
| P/TBV Ratio | 10.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.48 |
| EV / Sales | 261.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.21 |
Financial Position
The company has a current ratio of 10.63, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.63 |
| Quick Ratio | 7.72 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -1,061.13 |
Financial Efficiency
Return on equity (ROE) is -56.99% and return on invested capital (ROIC) is -36.43%.
| Return on Equity (ROE) | -56.99% |
| Return on Assets (ROA) | -34.36% |
| Return on Invested Capital (ROIC) | -36.43% |
| Return on Capital Employed (ROCE) | -43.45% |
| Revenue Per Employee | 116,409 |
| Profits Per Employee | -2.21M |
| Employee Count | 11 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.82% in the last 52 weeks. The beta is 0.85, so BXPHF's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +31.82% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 56.80 |
| Average Volume (20 Days) | 7,784 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BXPHF had revenue of 1.28 million and -24.32 million in losses. Loss per share was -0.01.
| Revenue | 1.28M |
| Gross Profit | -1.12M |
| Operating Income | -25.02M |
| Pretax Income | -24.32M |
| Net Income | -24.32M |
| EBITDA | -24.29M |
| EBIT | -25.02M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 29.98 million in cash and 536,141 in debt, giving a net cash position of 29.44 million.
| Cash & Cash Equivalents | 29.98M |
| Total Debt | 536,141 |
| Net Cash | 29.44M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 57.24M |
| Book Value Per Share | 0.03 |
| Working Capital | 38.01M |
Cash Flow
In the last 12 months, operating cash flow was -21.62 million and capital expenditures -103,381, giving a free cash flow of -21.72 million.
| Operating Cash Flow | -21.62M |
| Capital Expenditures | -103,381 |
| Free Cash Flow | -21.72M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -87.64% |
| Operating Margin | -1,954.28% |
| Pretax Margin | -1,898.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BXPHF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.08% |
| Shareholder Yield | n/a |
| Earnings Yield | -6.35% |
| FCF Yield | -5.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BXPHF has an Altman Z-Score of 41.89 and a Piotroski F-Score of 4.
| Altman Z-Score | 41.89 |
| Piotroski F-Score | 4 |